| USD ($) $ in Millions | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current assets: | |||||||||||||||||
ASSETS | |||||||||||||||||
Cash and cash equivalents | $ 3,368 | $ 2,027 | $ 2,750 | ||||||||||||||
Short-term investments | 2,567 | 1,986 | 2,473 | ||||||||||||||
Accounts receivable, net of allowances of $29.9 and $30.7 as of December 31, 2025, and 2024, respectively | 1,527 | 1,225 | 1,130 | ||||||||||||||
Inventory | 1,840 | 1,487 | 1,221 | ||||||||||||||
Prepaids and other current assets | 477 | 385 | 314 | ||||||||||||||
Deferred tax assets | 1,019 | 1,045 | 911 | ||||||||||||||
Total current assets | 9,780 | 7,111 | 7,888 | ||||||||||||||
Property, plant, and equipment, net | 5,342 | 4,647 | 3,538 | ||||||||||||||
Long-term investments | 3,099 | 4,819 | 2,120 | ||||||||||||||
Deferred tax assets | - | - | - | ||||||||||||||
Intangible and other assets, net | 849 | 774 | 637 | ||||||||||||||
Goodwill | 370 | 348 | 349 | ||||||||||||||
Other assets | - | - | - | ||||||||||||||
Total assets | 20,459 | 18,743 | 15,442 | ||||||||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||||
Current liabilities: | |||||||||||||||||
Accounts payable | 255 | 193 | 189 | ||||||||||||||
Accrued compensation and employee benefits | 648 | 536 | 436 | ||||||||||||||
Deferred revenue | 507 | 469 | 446 | ||||||||||||||
Other accrued liabilities | 596 | 548 | 588 | ||||||||||||||
Total current liabilities | 2,006 | 1,745 | 1,659 | ||||||||||||||
Other long-term liabilities | 511 | 468 | 386 | ||||||||||||||
Deferred revenue | - | - | - | ||||||||||||||
Total liabilities | 2,517 | 2,214 | 2,044 | ||||||||||||||
Stockholders’ equity: | |||||||||||||||||
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of December 31, 2025, and 2024 | 0 | 0 | 0 | ||||||||||||||
Common stock, 600.0 shares authorized, $0.001 par value, 355.1 shares and 356.6 shares issued and outstanding as of December 31, 2025, and 2024, respectively | 0 | 0 | 0 | ||||||||||||||
Additional paid-in capital | 10,769 | 9,681 | 8,576 | ||||||||||||||
Retained earnings | 7,012 | 6,803 | 4,743 | ||||||||||||||
Accumulated other comprehensive income (loss) | 43 | (51) | (12) | ||||||||||||||
Total Intuitive Surgical, Inc. stockholders’ equity | 17,824 | 16,434 | 13,308 | ||||||||||||||
Noncontrolling interest in joint venture | 118 | 96 | 90 | ||||||||||||||
Total stockholders’ equity | 17,942 | 16,530 | 13,397 | ||||||||||||||
Total liabilities and stockholders’ equity | $ 20,459 | $ 18,743 | $ 15,442 |